RxDoctor Payments Data

James Lovett, MD

Plastic Surgery · Greer, SCNPI 1952419863

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,102 of the $4,916 with a category attached, or 83.5%. 13 manufacturers reported payments, led by Mentor Worldwide LLC at 35.3% of the total. Reporting peaked in 2019 at $1,796 and has fallen 74.2% since, to $464 in 2025.

$4,916in general payments, 2019–2025

Across 146 payments — averaging $33.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mentor Worldwide LLC$2K
  • Medical Device Business Services, Inc.$1K
  • AbbVie$785
  • Sientra, Inc.$557
  • Musculoskeletal Transplant Foundation Inc.$452
  • Galderma Laboratories, L.p.$150
  • plus $197 from 7 others
$8,475in research payments, 2019–2025

Across 11 payments — averaging $770.45 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medical Device Business Services, Inc.$4K
  • Mentor Worldwide LLC$4K

What the payments were for

  • Travel & lodging$81317%
  • Food & beverage$4,10283%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,916 in reported general payments places this provider in the 75th percentile of 65 plastic surgery providers in South Carolina.

See all plastic surgery providers in South Carolina

Medicare billing

Part B allowed, 2024
$35,377
Medicare patients
54
Services billed
118

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cefadroxil40$155
Oxycodone Hcl17$68
Ondansetron OdtOndansetron13$25

Paid to pharmacies, not to this prescriber.

Other plastic surgery in Greer

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →